Chemkart India Ltd

₹ 197 0.64%

29 Sep - close price

About

Incorporated in 2020, Chemkart India Limited, based in Mumbai, is a B2B nutraceutical ingredient distributor and processor.^[1]

Key Points

Business Segment^[1]
a) Trading Business:(97% of H1FY25 revenue)^[2]
The company sources a wide range of nutraceutical ingredients—such as amino acids, vitamins, herbal extracts, and proteins—mainly through imports, and supplies them to B2B clients for manufacturing finished supplements.

Website BSE

Market Cap ₹ 239 Cr.
Current Price ₹ 197
High / Low ₹ 262 / 190
Stock P/E 9.83
Book Value ₹
Dividend Yield 0.00 %
ROCE 61.5 %
ROE 59.0 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 63.1%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Other Food Products

Part of BSE SME IPO

Edit Columns

Loading peers table ...

Detailed Comparison with:

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2024
	113
	93
Operating Profit	20
OPM %	18%
	1
Interest	1
Depreciation	0
Profit before tax	20
Tax %	26%
	15
EPS in Rs	108.62
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	87	131	132	203
	80	120	111	171
Operating Profit	7	11	21	33
OPM %	8%	8%	16%	16%
	0	0	1	2
Interest	0	1	1	2
Depreciation	0	0	0	1
Profit before tax	7	11	20	33
Tax %	25%	27%	27%	26%
	5	8	15	24
EPS in Rs	40.38	56.45	107.00	25.55
Dividend Payout %	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	33%
TTM:	54%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	64%
TTM:	67%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	63%
Last Year:	59%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	1	1	1	10
Reserves	5	13	28	44
	6	11	13	17
	12	12	12	16
Total Liabilities	25	37	54	86
	1	6	5	9
CWIP	0	0	0	0
Investments	0	0	0	0
	24	32	48	77
Total Assets	25	37	54	86

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-6	0	-0	4
	-1	-5	-0	-4
	7	5	0	3
Net Cash Flow	-0	0	-0	3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	80	62	87	82
Inventory Days	9	25	27	50
Days Payable	41	34	33	23
Cash Conversion Cycle	49	53	81	109
Working Capital Days	28	25	66	75
ROCE %		58%	63%	62%

Shareholding Pattern

Numbers in percentages

10 Recently

	Jul 2025
	73.31%
	1.77%
	9.14%
	15.78%
No. of Shareholders	1,190

	Jul 2025
	73.31%
	1.77%
	9.14%
	15.78%
No. of Shareholders	1,190

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

No data available.

Concalls

Sep 2025

Transcript

Notes
PPT